Columbia Wanger Asset Management’s PRA Health Sciences, Inc. PRAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
$77.5M Buy
851,276
+57,469
+7% +$4.78M 1.16% 6
2017
Q3
$60.5M Sell
793,807
-245,432
-24% -$18.5M 0.89% 24
2017
Q2
$78M Sell
1,039,239
-72,515
-7% -$5.03M 1.11% 9
2017
Q1
$72.5M Sell
1,111,754
-63,447
-5% -$3.74M 1.02% 14
2016
Q4
$64.8M Buy
1,175,201
+292,376
+33% +$16M 0.91% 23
2016
Q3
$49.9M Sell
882,825
-227,466
-20% -$11.2M 0.65% 54
2016
Q2
$46.4M Buy
+1,110,291
New +$51.2M 0.54% 80

Other funds holding PRAH

Columbia Wanger Asset Management's PRAH Position: Q4 2017 in Review

Columbia Wanger Asset Management increased its PRA Health Sciences, Inc. (PRAH) stake by 7.2% in Q4 2017, buying an estimated $4.78M and bringing the position to 851,276 shares worth $77.5M. The position accounts for 1.16% of the portfolio, ranked #6.

Columbia Wanger Asset Management first reported a position in PRAH in Q2 2016 and has held it in 7 quarters since. The position peaked at $78M in Q2 2017. 282 funds tracked by Wall St. Rank hold PRAH as of Q4 2017.

  • Columbia Wanger Asset Management held 851,276 shares of PRA Health Sciences, Inc. worth $77.5M as of Q4 2017.
  • Columbia Wanger Asset Management bought 57,469 PRA Health Sciences, Inc. shares in Q4 2017, an estimated $4.78M.
  • PRA Health Sciences, Inc. made up 1.16% of Columbia Wanger Asset Management's portfolio in Q4 2017, its #6 holding.
  • Columbia Wanger Asset Management first reported a position in PRA Health Sciences, Inc. in Q2 2016 and has held it in 7 quarters since.
  • Columbia Wanger Asset Management's PRA Health Sciences, Inc. position peaked at $78M in Q2 2017.
  • 282 funds tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q4 2017.

Based on Columbia Wanger Asset Management's 13F filing for Q4 2017, filed 13 Feb 2018.